Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema

Dermatologic Therapy

Volumn 21, Issue SUPPL. 2, 2008, Pages

  Schena, Donatella ^a,b   Papagrigoraki, Anastasia ^a   Girolomoni, Giampiero ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Allergic contact dermatitis; Chronic eczema; Sensitization; Triclosan

Indexed keywords

DICHROMATE POTASSIUM; FRAGRANCE; HAPTEN; HOUSE DUST ALLERGEN; LANOLIN ALCOHOL; NICKEL SULFATE; PHENYLENEDIAMINE; PROPOLIS; THIOMERSAL; TRICLOSAN;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CHILD; CONTACT DERMATITIS; DRUG HYPERSENSITIVITY; DRUG SAFETY; ECZEMA; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MYROXYLON; PATCH TEST; SKIN ALLERGY; SKIN SENSITIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS, LOCAL; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, ATOPIC; DERMATITIS, IRRITANT; ECZEMA; EMOLLIENTS; FEMALE; HAPTENS; HUMANS; INFANT; MALE; MIDDLE AGED; PATCH TESTS; TRICLOSAN; YOUNG ADULT;

EID: 53149100474     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2008.00231.x     Document Type: Article

References (18)

1. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature 1998 : 394 : 531 532.
2. Campbell L, Zirwas MJ. Triclosan. Dermatitis 2006 : 17 : 204 207.
3. Ledder RG, Gilbert P, Willis C, McBain AJ. Effect of chronic exposure upon the antimicrobial susceptibility of 40 ex-situ environmental and human isolates. J Appl Microbiol 2006 : 100 : 1132 1140.
4. Jones K, Fink-Gremmels J, Hardy T, et al. Report on triclosan's antimicrobial resistance. European Commission Health and Consumer Protection directorate-general. 2006 : Scientific Steering Committee : 1 17.
5. Sporick R. Topical triclosan treatment of atopic dermatitis. J Allergy Clin Immunol 1997 : 99 : 861.
6. Bhargava HN, Leonard PA. Triclosan: applications and safety. AJIC 1996 : 24 : 209 218.
7. Wilkinson DS, Fregert S, Magnusson B, et al. Terminology of contact dermatitis. Acta Derm Venereol 1970 : 50 : 287 292.
8. Wong CS, Beck MH. Allergic contact dermatitis from triclosan in antibacterial handwashes. Contact Dermatitis 2001 : 45 : 307.
9. Dastychovà E, Necas M, Pencikovà K, Cerny P. Contact sensitization to pharmaceutic aid in dermatologic cosmetic and external use preparation. Ceska Slov Farm 2004 : 53 : 151 156.
10. Perrenoud D, Bircher A, Hunziker T, et al. Frequency of sensitization to 13 common preservatives in Switzerland. Swiss Contact Dermatitis Research Group. Contact Dermatitis 1994 : 30 : 276 279.
11. Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev 2004 : 17 : 863 893.
12. Roesch A, Linde HJ, Landthaler M, Vogt T. Elimination of a community acquired methicillin-resistant Staphylococcus aureus infection in a nurse with atopic dermatitis. Arch Dermatol 2005 : 141 : 1520 1522.
13. Zafar RC, Butier Reese DJ, Gaydos LA, Mennonna PA. Use of 0.3% triclosan (Bacti-Stat*) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 1995 : 23 : 200 208.
14. Webster J, Faoagali JL, Cartwright D. Elimination of methicillin- resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. J Pediatr Child Health 1994 : 30 : 59 64.
15. Kolmer LH, Taketomi EA, Hazen KC, Hughs E, Wilson BB, Platts-Mills TAE. Effect of combined antibacterial and antifungal treatment in severe atopic dermatitis. J Allergy Clin Immunol 1996 : 98 : 702 707.
16. Wohlrab J, Jost G, Abeck D. Antiseptic efficacy of a low-dosed topical triclosan-clorhexidine combination therapy in atopic dermatitis. Skin Pharmacol Physiol 2007 : 20 : 71 76.
17. Kjaerheim V, Barkvoll P, Waaler SM, Rolla G. Triclosan inhibits histamine-induced inflammation in human skin. J Clin Periodontol : 199 (22 423 426.
18. Barkvoll P, Rolla G. Triclosan reduces the clinical symptoms of the allergic patch test reaction (APR) elicited with 1% nickel sulphate in sensitized patients. J Clin Periodontol 1995 : 22 : 485 487.